The Latest in Oncology Practice

New and emerging therapies for malignant pleural disease

December 13, 2012

Lung Cancer

Good news for apixaban in recurrent VTE prevention

December 13, 2012

Patient & Survivor Care

HERA: Trastuzumab survival benefit strong at 8 years

December 13, 2012

Breast Cancer

Bevacizumab misses - again - for breast cancer

December 12, 2012

Breast Cancer

FDA approves abiraterone use ahead of prostate cancer chemotherapy

December 12, 2012

Genitourinary Cancer

Neoadjuvant chemo benefits young women with triple-negative breast cancer

December 12, 2012

Breast Cancer

Long-term income growth slow for physicians

December 12, 2012

Practice Management

Trastuzumab survival benefit still significant 10 years later

December 12, 2012

Breast Cancer

Eribulin fails to best capecitabine in advanced breast cancer

December 12, 2012

Breast Cancer

Experimental quizartinib gives bridge to transplant in relapsed AML

December 11, 2012

Leukemia, Myelodysplasia, Transplantation

ASH12: New Myeloma Drug Works Better with Low-Dose Dexamethasone

December 11, 2012

Lymphoma & Plasma Cell Disorders

HEM-ONC CHAT: Dr. Elias Jabbour, 'Treatment a la Carte in CML'

December 11, 2012

Leukemia, Myelodysplasia, Transplantation

ONC-CHAT: Dr. Martine Piccart, 'Absolutely No Advantage' to 2 Years of Trastuzumab

December 11, 2012

Breast Cancer

Fewer Deaths with Tighter Hematocrit Target in Polycythemia Vera

December 10, 2012

ASH12: New Proteasome Inhibitor Shines In All-Oral Myeloma Regimen

December 10, 2012

Lymphoma & Plasma Cell Disorders